论文信息 - Deferasirox (Exjade®, ICL670) Demonstrates Iron Chelating Efficacy Related to Transfusional Iron Intake in Pediatric Patients. - 字舞流文

Deferasirox (Exjade®, ICL670) Demonstrates Iron Chelating Efficacy Related to Transfusional Iron Intake in Pediatric Patients.

J. Ford | T. Klingebiel | Y. Kilinç | K. Bourantas | A. Maggio | D. Canatan | C. Kattamis | A. Ferster | S. Fattoum | D. Gallisai | M. Dresse | Insa Gathmann | Henry Maseruka